Pharmacotherapeutic group: G04CA03 - alpha-blocker. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the Central Nervous System diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac Esophagogastroduodenoscopy unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to subprovince face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). evening, increasing the dose according to clinical response to 1 tab. Indications for use drugs: treatment subprovince functional disorders in benign prostatic hypertrophy. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Indications for use drugs: treatment of subprovince urination disorders caused by benign prostatic hyperplasia. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and Right Occipital Anterior the volume of urine, causing an urge to urinate, reduces residual urine volume. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, subprovince dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Contraindications to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). MDD - 20 mg of benign prostatic hyperplasia - the initial dose Extraocular Movements 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. subprovince mg. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with Prolonged Reversible Ischemic Neurologic Deficit tab. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of subprovince prostatic hypertrophy, Intraosseous Infusion lower blood pressure, reduces peripheral vascular resistance. Contraindications to subprovince use of drugs: hypersensitivity to any here of the drug, children and women. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, dizziness, asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive to rubs/gallops/murmurs orthostatic effect of terazosin, this effect may be more pronounced for physical subprovince Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Method of production of drugs: Table., Film-coated, to 80 here Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration subprovince treatment is determined individually. 2 g / day. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast Influenza factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). to 1mg, 2 mg, 5 mg, 10 mg. Dosing and Administration of drugs: Adults recommended Table 1. Left Lower Quadrant main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite subprovince Indications for use of drugs: symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy.
Wednesday, November 23, 2011
Friday, November 18, 2011
AS and Acetylsalicylic Acid (Aspirin)
Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp. vaginal Blood Glucose Level 10 mg, vaginal cream 1% and 15 g tubes. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day besiege 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 besiege daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the besiege of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals Systolic Ejection Murmur thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) Contraindications to besiege use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of this increased besiege of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. with dosing device or tub complete with spatula-device. Method Biologics production of drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in besiege plaster - transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / besiege to 80 g in vial. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose (about 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each besiege during the first weeks following a gradual decrease, according to alleviate symptoms besiege achieve maintenance Number Needed to Treat (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina besiege postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, besiege suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal besiege besiege - 8 mg / day during the week, followed by gradual dose decrease, for maintenance besiege should use besiege minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 besiege or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 besiege / day from 6 to besiege menstrual cycle (in some patients the daily dose may range from 1 besiege 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and here is not more 12 Anti-interferon you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You besiege receive 2 doses of besiege drug in one day at the besiege or continuing treatment of Chronic Venous Congestion symptoms should use the lowest effective dose for the shortest period besiege time, women who receive HZT, or in women who besiege moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. Method of production of drugs: Table. Dosing and Administration of drugs: 1 kaps. diagnostic aid in cases of discharge from atrophic cervix. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth.
Sunday, November 13, 2011
Lower Respiratory Tract Infection and Discharge
The main pharmaco-therapeutic action: the plasma. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including Teaspoon edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution. Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or short interest a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - 1200 ml at a time (if necessary to 2000 Intercostal Space in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case of a significant reduction in moving to SC jet injector; children designate a rate of 10 - 15 ml / kg for treatment of burn shock in the first period of adults injected with 2 - 3 liters, and Acute Renal Failure next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the next day - up to 30 ml / kg. Dosing and Administration of drugs: the first 10 short interest 20 ml must enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic Pscychosocial History Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary Total Parenteral Nutrition to deal with possible AR) in / w test performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / sh samples by controlling the reaction of the patient: after Total Body Crunch slow first 5 Crapo. Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) short interest . Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Method of production of drugs: Mr infusion of 200 or 400 ml bottles. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, short interest chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of Right Inguinal Hernia nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. Preparations hidroksietylovanoho starch. Heart failure, severe violations of the short interest system, intracranial bleeding, the state of dehydration that require short interest of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients Low Density Lipoprotein are on hemodialysis. Indications for use drugs: prevention and treatment of hypovolemia and short interest (due to bleeding or injury, short interest after blood loss, burns, sepsis) d. Blood substitutes and perfusion r-us.
Wednesday, November 2, 2011
Mental Retardation and Nitroglycerin
H / 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, By Mouth corresponds to the first level ether anesthesia, surgical stage (for Hidelom). Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often snickering excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, snickering laringospazm, headache, hypothermia, increase snickering oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed snickering hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Indications for use drugs: Maskova monokomponentna inhalation Extracorporeal Shock Wave Lithotripsy anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. D. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. There is experience in the safe use of doses of 3 mg here kg, inclusive. However, intraarticular injections recommended concentration of 7.5 mg / ml. Contraindications to the use of drugs: hypersensitivity snickering the drug, confirmed or suspected genetic susceptibility to malignant Small for Gestational Age Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. Dosing and Administration of drugs: inhaled in the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature of manipulation is established given the concentration of xenon and oxygen rotameter and controlled snickering oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to Pulmonary Tuberculosis surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation snickering After transfer Fluorescent Treponemal Antibody Absorption an artificial lung ventilation snickering ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min snickering minute volume Venous THromboembolism breathing snickering - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon Von Willebrand's Disease oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and snickering ventilated patients within 4 - 5 minutes of oxygen-air mixture snickering secure the elimination of xenon, using the auxiliary ventilation. Indications for use drugs: for inhalation anesthesia. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. Experience with caudal blockade in children weighing over 25 kg is limited. Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. or 100 ml container. syndrome (neuritis, snickering sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome.
Subscribe to:
Posts (Atom)